Structural Optimization of Carboxy-Terminal Phenylalanine-Modified Dendrimers for T-Cell Association and Model Drug...

Area of Science:

• Nanotechnology
• Drug Delivery
• Immunology

Background:

• Dendrimers are precisely controllable nanocarriers for drug delivery.
• Previous studies showed polyamidoamine (PAMAM) dendrimers modified with 1,2-cyclohexanedicarboxylic acid (CHex) and phenylalanine (Phe) associate with T-cells.

Purpose of the Study:

• Synthesize and evaluate carboxy-terminal Phe-modified dendrimers for T-cell association.
• Investigate the drug loading and cytotoxicity of promising dendrimer candidates.

Main Methods:

• Synthesized various carboxy-terminal Phe-modified dendrimers using phthalic acid and linear dicarboxylic acids.
• Assessed dendrimer association with Jurkat T-cells.
• Loaded model drugs (protoporphyrin IX, paclitaxel) onto dendrimers.
• Evaluated cytotoxicity of drug-loaded dendrimers.

Main Results:

• PAMAM-n-hexyl-Phe showed the highest association with Jurkat T-cells.
• Dendri-graft polylysine (DGL)-CHex-Phe exhibited higher T-cell association but poor water solubility.
• PAMAM-CHex-Phe demonstrated superior drug loading capacity.
• PTX-loaded PAMAM-CHex-Phe showed comparable cytotoxicity to free paclitaxel.

Conclusions:

• PAMAM-CHex-Phe is a suitable nanocarrier with efficient T-cell association and drug loading capabilities.
• This dendrimer shows potential for targeted drug delivery to T-cells.